PURPOSE OF REVIEW: The purpose of this study is to summarize the role of anti-Müllerian hormone (AMH) in assisted reproductive technology (ART) treatment. RECENT FINDINGS: AMH is a good marker in the prediction of ovarian response to controlled ovarian hyperstimulation. In clinical practice, this means that AMH may be used for identifying poor or excessive responders. So far, studies show that AMH is not a good predictor for the occurrence of pregnancy after ART treatment. Therefore, routine screening for a poor ovarian reserve status using AMH is not to be advocated. Still, ovarian response prediction using AMH may open ways for patient-tailored stimulation protocols in order to reduce cancellations for excessive response, possibly improve pregnancy prospects and reduce costs. SUMMARY: AMH is able to predict extremes in ovarian response to controlled ovarian hyperstimulation but cannot predict pregnancy after ART treatment. Its future clinical role may be in the individualization of ART stimulation protocols.
PURPOSE OF REVIEW: The purpose of this study is to summarize the role of anti-Müllerian hormone (AMH) in assisted reproductive technology (ART) treatment. RECENT FINDINGS:AMH is a good marker in the prediction of ovarian response to controlled ovarian hyperstimulation. In clinical practice, this means that AMH may be used for identifying poor or excessive responders. So far, studies show that AMH is not a good predictor for the occurrence of pregnancy after ART treatment. Therefore, routine screening for a poor ovarian reserve status using AMH is not to be advocated. Still, ovarian response prediction using AMH may open ways for patient-tailored stimulation protocols in order to reduce cancellations for excessive response, possibly improve pregnancy prospects and reduce costs. SUMMARY:AMH is able to predict extremes in ovarian response to controlled ovarian hyperstimulation but cannot predict pregnancy after ART treatment. Its future clinical role may be in the individualization of ART stimulation protocols.
Authors: Sezai Sahmay; Mahmut Oncul; Abdullah Tuten; Abdullah Tok; Abdullah Serdar Acıkgoz; Ismail Cepni Journal: J Assist Reprod Genet Date: 2014-09-04 Impact factor: 3.412
Authors: Pierre Lehmann; Maria P Vélez; Julio Saumet; Louise Lapensée; Wael Jamal; François Bissonnette; Simon Phillips; Isaac-Jacques Kadoch Journal: J Assist Reprod Genet Date: 2014-02-27 Impact factor: 3.412
Authors: Sunni L Mumford; Richard S Legro; Michael P Diamond; Christos Coutifaris; Anne Z Steiner; William D Schlaff; Ruben Alvero; Gregory M Christman; Peter R Casson; Hao Huang; Nanette Santoro; Esther Eisenberg; Heping Zhang; Marcelle I Cedars Journal: J Clin Endocrinol Metab Date: 2016-05-26 Impact factor: 5.958
Authors: K Morarji; O McArdle; K Hui; G Gingras-Hill; S Ahmed; E M Greenblatt; E Warner; S Sridhar; A M F Ali; A Azad; D C Hodgson Journal: Curr Oncol Date: 2017-12-20 Impact factor: 3.677
Authors: Hang Wun Raymond Li; Vivian Chi Yan Lee; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho; Ernest Hung Yu Ng Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240